You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ETRA Conversion Disclosure
Stagliano Nancy · SEC Form 4 · Filed Sep 21, 2026
Conversion
Reported value range
Not reported
Stagliano Nancy Director
ETRA
Transaction date
Sep 21, 2026
Public filing date
Sep 21, 2026
Filing lag
Filed same day
ETRA daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series A Convertible Preferred Stock on Common Stock
- Quantity / price
- 255,635 shares
- SEC ownership
- Direct
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001817449-26-000009
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Electra Therapeutics, Inc. ETRA | Conversion | Sep 21, 2026 | Not reported |
| Electra Therapeutics, Inc. ETRA Current | Conversion | Sep 21, 2026 | Not reported |